UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 179

Sortiert nach

Pharmacokinetic Study of Antiviral Drugs in Patients with COVID-19

YAKUGAKU ZASSHI, 2023/03/01, Vol.143(3), pp.239-241

Irie, Kei

2023

Volltextzugriff (PDF)

Remarks about the C∞-closing lemma for 3-dimensional Reeb flows

Kyoto journal of mathematics, 2021-06, Vol.61 (2)

Irie, Kei

2021

Volltextzugriff (PDF)

Density of minimal hypersurfaces for generic metrics

Annals of mathematics, 2018-05, Vol.187 (3), p.963-972

2018

Volltextzugriff (PDF)

Hofer–Zehnder capacity of unit disk cotangent bundles and the loop product

Journal of the European Mathematical Society : JEMS, 2014-01, Vol.16 (11), p.2477-2497

Irie, Kei

2014

Volltextzugriff (PDF)

Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

British journal of cancer, 2018-01, Vol.118 (1), p.32-37

2018

Volltextzugriff (PDF)

Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid

International journal of infectious diseases, 2022-03, Vol.116, p.223-225

2022

Volltextzugriff (PDF)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19

Clinical and translational science, 2020-09, Vol.13 (5), p.880-885

2020

Volltextzugriff (PDF)

A C∞ closing lemma for Hamiltonian diffeomorphisms of closed surfaces

Geometric and functional analysis, 2016-10, Vol.26 (5), p.1245-1254

2016

Volltextzugriff (PDF)

Osimertinib in a patient with non-small cell lung cancer and renal failure undergoing hemodialysis: a case report

Investigational new drugs, 2020-08, Vol.38 (4), p.1192-1195

2020

Volltextzugriff (PDF)

Serum concentration of the CKD4/6 inhibitor abemaciclib, but not of creatinine, strongly predicts hematological adverse events in patients with breast cancer: a preliminary report

Investigational new drugs, 2021-02, Vol.39 (1), p.272-277

2021

Volltextzugriff (PDF)

Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib

European journal of clinical pharmacology, 2022-08, Vol.78 (8), p.1239-1247

2022

Volltextzugriff (PDF)

Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication

Therapeutic drug monitoring, 2023-12, Vol.45 (6), p.823

2023

Volltextzugriff (PDF)

Encephalopathy induced by high levels of ceftriaxone in the blood and cerebrospinal fluid

IDCases, 2022-01, Vol.29, p.e01581, Article e01581

2022

Volltextzugriff (PDF)

Strong closing property of contact forms and action selecting functors

Journal of fixed point theory and applications, 2024-06, Vol.26 (2), Article 15

Irie, Kei

2024

Volltextzugriff (PDF)

Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer

Therapeutic drug monitoring, 2023-02, Vol.45 (1), p.110

2023

Volltextzugriff (PDF)

Pharmacokinetic Study of Antiviral Drugs in Patients with COVID-19

Yakugaku zasshi, 2023-03, Vol.143 (3), p.239-241, Article 22-00169-1

Irie, Kei

2023

Volltextzugriff (PDF)

Population pharmacokinetics of favipiravir in patients with COVID‐19

CPT: pharmacometrics and systems pharmacology, 2021-10, Vol.10 (10), p.1161-1170

2021

Volltextzugriff (PDF)

Pharmacokinetics and clinical outcomes of nivolumab administered every 4 weeks in patients with advanced non-small-cell lung cancer: A four-case pilot study

Respiratory investigation, 2021-07, Vol.59 (4), p.545-549

2021

Volltextzugriff (PDF)

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide

Frontiers in pharmacology, 2022-05, Vol.13, p.901099-901099

2022

Volltextzugriff (PDF)

Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms

Cancer chemotherapy and pharmacology, 2019-01, Vol.83 (1), p.107-113

2019

Volltextzugriff (PDF)

Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19

CPT: pharmacometrics and systems pharmacology, 2023-04, Vol.12 (4), p.513-521

2023

Volltextzugriff (PDF)

Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem‐Cell Transplantation

Journal of clinical pharmacology, 2018-09, Vol.58 (9), p.1140-1149

2018

Volltextzugriff (PDF)

Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts

Journal of clinical pharmacy and therapeutics, 2021-02, Vol.46 (1), p.190-197

2021

Volltextzugriff (PDF)

Capacities of billiard tables and $$S^1$$-equivariant loop space homology

Journal of fixed point theory and applications, 2022-06, Vol.24 (2), Article 51

Irie, Kei

2022

Volltextzugriff (PDF)

Pharmacokinetic analysis for model‐supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients

Pediatric transplantation, 2020-06, Vol.24 (4), p.e13696-n/a

2020

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Englisch
(160)
Japanisch
(59)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic Study of Antiviral Drugs in Patients with COVID-19

Remarks about the C∞-closing lemma for 3-dimensional Reeb flows

Density of minimal hypersurfaces for generic metrics

Hofer–Zehnder capacity of unit disk cotangent bundles and the loop product

Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19

A C∞ closing lemma for Hamiltonian diffeomorphisms of closed surfaces

Osimertinib in a patient with non-small cell lung cancer and renal failure undergoing hemodialysis: a case report

Serum concentration of the CKD4/6 inhibitor abemaciclib, but not of creatinine, strongly predicts hematological adverse events in patients with breast cancer: a preliminary report

Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib

Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication

Encephalopathy induced by high levels of ceftriaxone in the blood and cerebrospinal fluid

Strong closing property of contact forms and action selecting functors

Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer

Pharmacokinetic Study of Antiviral Drugs in Patients with COVID-19

Population pharmacokinetics of favipiravir in patients with COVID‐19

Pharmacokinetics and clinical outcomes of nivolumab administered every 4 weeks in patients with advanced non-small-cell lung cancer: A four-case pilot study

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide

Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms

Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19

Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem‐Cell Transplantation

Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts

Capacities of billiard tables and $$S^1$$-equivariant loop space homology

Pharmacokinetic analysis for model‐supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients

Suchergebnisse filtern